Bristol-Myers Is For Sale
Bristol-Myers Squibb, the $20 billion (sales) pharmaceutical giant, has put itself up for sale, according to a news report from Reuters. Itself a product of the 1989 merger of Bristol-Myers and Squibb Corporation, the company is said to be examining a number of options, including a possible combination with GlaxoSmithKline.
Click here to read the Reuters report.
Want to use this article? Click here for options!
© 2012 Penton Media Inc.
Acceptable Use Policy blog comments powered by Disqus
Advertisement
Advertisement
Sign Up for Our Free E-Newsletters
Meetings Collaborative
Rate your experience with meeting venues and suppliers.
| Powered by: Meetings Collaborative | |
Latest Webinar
Global Meetings: Risk Management A to ZFebruary 28 | 2p.m. EST
Organizations take on more risk than usual when booking meetings outside the U.S. Join our expert panelists and learn how to assess your overall risk, write contracts that protect your organization, manage currency exchange rate fluctuations, keep your travelers safe, and much more.
View it on-demand now!
VIEW ALL ARCHIVED WEBINARS
Advertisement
